CXCR1 and benign prostatic hyperplasia: In the presence of a CXCR1-specific neutralizing monoclonal antibody, the proliferation pathway of BPH cells induced by IFN-γ/IL-17 was blocked, but the IL-8-dependent loop was involved in the autocrine/paracrine proliferation of BPH cells.